NewGenIvf Group (NASDAQ:NIVF) and iSpecimen (NASDAQ:ISPC) Critical Survey

NewGenIvf Group (NASDAQ:NIVF) and iSpecimen (NASDAQ:ISPC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Volatility & Risk

NewGenIvf Group has a beta of -0.06, indicating that its share price is 106% less volatile than the S&P 500. Comparatively, iSpecimen has a beta of 1.81, indicating that its share price is 81% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations for NewGenIvf Group and iSpecimen, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NewGenIvf Group	1	0	0	0	1.00
iSpecimen	1	0	0	0	1.00

Profitability

This table compares NewGenIvf Group and iSpecimen’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NewGenIvf Group	N/A	N/A	N/A
iSpecimen	-172.48%	-395.15%	-121.72%

Valuation & Earnings

This table compares NewGenIvf Group and iSpecimen”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NewGenIvf Group	$5.43 million	0.73	-$520,000.00	N/A	N/A
iSpecimen	$5.91 million	1.07	-$12.50 million	($9.51)	-0.12

NewGenIvf Group has higher earnings, but lower revenue than iSpecimen.

Insider and Institutional Ownership

66.2% of NewGenIvf Group shares are owned by institutional investors. Comparatively, 13.6% of iSpecimen shares are owned by institutional investors. 31.8% of NewGenIvf Group shares are owned by insiders. Comparatively, 12.2% of iSpecimen shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

NewGenIvf Group beats iSpecimen on 6 of the 9 factors compared between the two stocks.

About NewGenIvf Group

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company was founded by Siu Wing Fung and Fong Hei Yue on January 16, 2019 and is headquartered in Bangkok, Thailand.

About iSpecimen

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.